• Education
• Outreach
• Research
• Patient Care
• People

Myra Muramoto, MD, MPH

DOD (Lando PI; Muramoto Co-I) 10/01/2002 - 9/30/2007 .
A Model DOD Systems Approach for Tobacco Cessation.
This major goal of this project is to evaluate a multi-channel system intervention to increase smoking cessation in a military population.
Role: Co-Investigator

HRSA/MCHB TO2 6/1/2002 - 11/30/2006 .
Distance Learning to Enhance MCH Substance Abuse Services
The major goal of this project is to develop three distance learning course about substance abuse for maternal child health professionals.
Role: Principal Investigator

NIH/Fogarty R01 (Lando PI; Muramoto Co-I) 7/1/2002 - 6/30/2007
Cessation Research and Training in India and Indonesia
The major purpose of this project is to develop the tobacco cessation research capacity of researchers in India and Indonesia.
Role: Co-Investigator

NCI RO1 9/26/2002 - 8/31/2006
Community-based Training Models for Tobacco Cessation
The major purpose of this project is to develop an internet-based tobacco cessation training and conduct a randomized controlled trial of the internet training compared to a traditional in-person training.
Role: Principal Investigator

Sanofi-Synthelabo 1/1/2003 -3/31/2006
Comparison of the efficacy and safety of 2 oral doses of rimonabant versus placebo
The study is a double blind, randomized, placebo-controlled parallel-group fixed dose clinical trial to evaluate the safety and efficacy of rimonabant for smoking cessation and maintenance in adults.
Role: Principal Investigator

Pfizer 2/4/2004 -11/3/2005
A Twelve-Week Double-Blind, Placebo-Controlled, Randomized, Multicenter Study with Follow-Up Evaluating the Safety and Efficacy of Varenicline Tartrate (CP-526,555) in Comparison to Zyban for Smoking Cessation.
Role: Principal Investigator

HHS/National Cancer Institute R21 9/1/05 - 8/31/07
Brief Tobacco Intervention Training in Childcare Centers
The major purpose of this project is to train childcare center workers to conduct brief tobacco interventions to prepare them to more effectively influence parental tobacco use behavior and determine the potential utility and impact of the BI training.
Role: Principal Investigator

Pfizer, Pharmacia & Upjohn 5/08/06 - 11/15/06
A multicenter Randomized, Parallel Group, Comparative Trial to Evaluate the Efficacy of Nicotine Hydrogen Tartrate Gum (4mg) and a Coated Nicotine Polacrilex Gum (4 mg) versus Uncoated Nicotine Polacriles Gum (4 mg) on the Speed to Subjectively Meaningful Relief of Acute Craving in Adult Smokers
Role: Principal Investigator

R21 (Ritenbaugh) 04/06-03/08
Preventing CVD in Native Populations: The Traditional Living Challenge.
This project, designed and implemented in full partnership with Salish Kootenai College, will develop and test a traditional lifestyle experience to enhance behavioral change with regard to cardiovascular disease risk factors.
Role: Investigator

NIDDK R34 (Bassford) 07/01/06- 06/30/08
Group Visits for Treating Type 2 Diabetes in Hispanics
This planning grant will pilot test a group office visit model for the clinical care of type 2 diabetes, and plan for a multi-clinic randomized trial.
Role: Investigator